Medicines Co. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
377
371
373
542
151
241
Total Accounts Receivable
102
156
52
18
3
-
Inventories
87
79
65
28
6
1
Other Current Assets
26
18
343
65
403
53
Total Current Assets
591
624
833
654
563
295
Net Property, Plant & Equipment
39
38
35
31
17
9
Total Investments and Advances
9
1
1
5
6
7
Intangible Assets
1,094
826
926
523
201
201
Other Assets
8
363
1
493
86
331
Total Assets
1,741
1,886
1,916
1,705
873
842
ST Debt & Current Portion LT Debt
-
-
255
54
-
Accounts Payable
27
20
36
21
10
Other Current Liabilities
147
384
243
170
165
Total Current Liabilities
174
404
534
245
175
Long-Term Debt
236
247
312
624
649
Provision for Risks & Charges
-
98
97
32
15
Deferred Taxes
129
72
90
90
-
Other Liabilities
310
112
13
62
9
Total Liabilities
849
966
1,167
1,052
848
Common Equity (Total)
892
921
732
653
25
Total Shareholders' Equity
892
921
732
653
25
Total Equity
892
920
732
652
25
Liabilities & Shareholders' Equity
1,741
1,886
1,916
1,705
873
Accumulated Minority Interest
-
-
-
1
-
Non-Equity Reserves
-
-
17
1
-

About Medicines

View Profile
Address
8 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.themedicinescompany.com
Updated 07/08/2019
The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A.